Literature DB >> 2485038

Tissue renin-angiotensin system: sites of angiotensin formation.

D J Campbell1.   

Abstract

The classical concept of the renin-angiotensin system as an endocrine system, whereby angiotensin is generated in the circulation and conveyed by blood to peripheral tissues, is being increasingly challenged by evidence that suggests that peripheral tissues are the major site of generation of angiotensin I and II. The concentrations of angiotensins I and II in arterial and venous blood, taken together with their efficient metabolic clearance by peripheral tissues and their slow rate of generation in blood, indicate that peripheral tissues are the major site of generation of these peptides. Most angiotensin I and II in blood is generated within tissues by the action of plasma-derived renin on plasma-derived angiotensinogen, and the action of tissue converting enzyme. In addition, there is increasing evidence for the synthesis of renin by tissues other than the kidney, and of angiotensinogen by tissues other than the liver. The relative contribution of plasma renin and angiotensinogen, and of locally synthesized renin (or renin-like enzyme) and angiotensinogen, to angiotensin generation in each tissue is unknown, and probably differs between tissues. These two mechanisms for local generation of angiotensin within tissues have the potential to produce changes in tissue concentrations of angiotensin that are independent of the circulating level of renin and angiotensin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2485038     DOI: 10.1097/00005344-198706107-00002

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  11 in total

1.  Differential regulation of angiotensin-(1-12) in plasma and cardiac tissue in response to bilateral nephrectomy.

Authors:  Carlos M Ferrario; Jasmina Varagic; Javad Habibi; Sayaka Nagata; Johji Kato; Mark C Chappell; Aaron J Trask; Kazuo Kitamura; Adam Whaley-Connell; James R Sowers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-02-13       Impact factor: 4.733

Review 2.  Proximal nephron.

Authors:  Jia L Zhuo; Xiao C Li
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

3.  Review: Intrarenal angiotensin II levels in normal and hypertensive states.

Authors:  L Gabriel Navar; Kenneth D Mitchell; Lisa M Harrison-Bernard; Hiroyuki Kobori; Akira Nishiyama
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2001-03       Impact factor: 1.636

Review 4.  Biochemistry and pharmacology of the renin-angiotensin system.

Authors:  C I Johnston
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 5.  Intrarenal angiotensinogen: localization and regulation.

Authors:  J R Ingelfinger; H Schunkert; K E Ellison; M Pivor; W M Zuo; R Pratt; V J Dzau
Journal:  Pediatr Nephrol       Date:  1990-07       Impact factor: 3.714

Review 6.  Is the renin-angiotensin system actually hypertensive?

Authors:  Etienne Bérard; Olivier Niel; Amandine Rubio
Journal:  Pediatr Nephrol       Date:  2013-06-06       Impact factor: 3.714

Review 7.  Dynamic regulation of the angiotensinogen gene by DNA methylation, which is influenced by various stimuli experienced in daily life.

Authors:  Masashi Demura; Yosiki Demura; Yoshiyu Takeda; Kiyofumi Saijoh
Journal:  Hypertens Res       Date:  2015-03-26       Impact factor: 3.872

8.  A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro.

Authors:  I Inoue; T Nakajima; C S Williams; J Quackenbush; R Puryear; M Powers; T Cheng; E H Ludwig; A M Sharma; A Hata; X Jeunemaitre; J M Lalouel
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

9.  Possible Mechanisms of Local Tissue Renin-Angiotensin System Activation in the Cardiorenal Metabolic Syndrome and Type 2 Diabetes Mellitus.

Authors:  Melvin R Hayden; Kurt M Sowers; Lakshmi Pulakat; Tejaswini Joginpally; Bennett Krueger; Adam Whaley-Connell; James R Sowers
Journal:  Cardiorenal Med       Date:  2011-07-30       Impact factor: 2.041

10.  Coronary vasodilation induced by captopril and zofenoprilat: evidence for a prostaglandin-independent mechanism.

Authors:  J van Wijngaarden; R A Tio; W H van Gilst; P A de Graeff; C D de Langen; H Wesseling
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.